CU
CURG.LSE VanEck Genomics and Healthcare Innovators UCITS ETF GBP
- GBP
No recent price
- Total assets
- 24.7M
- Expense ratio
- 0.36%
- Dividend yield
- -
- 1-year return
- +34.81%
- Holdings
- 49
- Since
- 2022
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does CURG.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (87.6%)
- Largest sector: Healthcare (99.9%)
- Largest region: North America (89.9%)
- Top 3 holdings: 26.2% of the fund
Asset allocation
- US stocks 87.6%
- Non-US stocks 8.6%
Top holdings
- Moderna Inc 9.98%
- Regeneron Pharmaceuticals Inc 8.51%
- Vertex Pharmaceuticals Inc 7.67%
- Veeva Systems Inc Class A 7.14%
- Natera Inc 6.80%
VanEck Genomics and Healthcare Innovators UCITS ETF GBP performance
Sharpe ratio 0.79- This year
- +34.99%
- 1 year
- +34.81%
- 3 years
- +18.17%
- 5 years
- 0.00%
Volatility 25.9% over 1 year and 20.0% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
CURG.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
VanEck Genomics and Healthcare Innovators UCITS ETF GBP top holdings
60.2% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 9.98% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 8.51% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 7.67% |
| Veeva Systems Inc Class A VEEV.US | Healthcare | United States | 7.14% |
| Natera Inc NTRA.US | Healthcare | United States | 6.80% |
| Illumina Inc ILMN.US | Healthcare | United States | 5.09% |
| DexCom Inc DXCM.US | Healthcare | United States | 4.66% |
| Guardant Health Inc GH.US | Healthcare | United States | 4.38% |
| BioNTech SE BNTX.US | Healthcare | United States | 3.36% |
| Alnylam Pharmaceuticals Inc ALNY.US | Healthcare | United States | 2.62% |
The 10 largest of 49 holdings.
CURG.LSE sector exposure
- Healthcare99.9%
Share of the stocks in the fund.
CURG.LSE regional exposure
- North America89.9%
- Europe Developed3.0%
- Australasia2.2%
- Asia Emerging2.0%
- Japan1.3%
- United Kingdom0.6%
Share of the stocks in the fund.
Company size
Average market cap 25.0B- Big cap11.1%
- Medium cap52.7%
- Small cap26.6%
- Micro cap6.2%
VanEck Genomics and Healthcare Innovators UCITS ETF GBP fund profile
- Fund name
- VanEck Genomics and Healthcare Innovators UCITS ETF GBP
- Ticker
- CURG.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Sep 2, 2022
- Trading currency
- GBP
- Expense ratio
- 0.36%